Presidio Partners is a venture capital firm based in San Francisco that invests in IT, life sciences, and energy technology companies. Founded 2015 in San Francisco, California, United States, this venture capital form invests in series B, series C and series D rounds. Its portfolio companies include ESS, Wildcat Discovery Technologies, Solaria, Menlo Therapeutics, Mojo Networks, Cnano Technology, and SurgiQuest. Presidio Partners has made 11 investments. Their most recent investment was on Oct 28, 2019, when ESS raised $30M. Presidio Partners has had 4 exits, the most most notable of which include Mojo Networks, Menlo Therapeutics, and Neos Therapeutics. The company has raised a single venture fund, Presidio Partners 214. This fund was announced on Apr 21, 2015 and raised a total of $142M.
A clinical late-stage biopharmaceutical company in California that focuses on treatments of dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.
Cnano Technology is a Santa Clara, California-based producer of carbon nanotubes and advanced energy applications.
Managing Director and Portfolio Manager
Documentaries, videos and podcasts
Wildcat Discovery Technologies